The Science of Aging: Telomeres, Peptides, and Whether Facelifts Will Become Obsolete

The Science of Aging: Telomeres, Peptides, and Whether Facelifts Will Become Obsolete

What if the future of facial rejuvenation isn't a facelift — it's reversing aging itself? In Part 2 of their modern facelift series, Dr. Ben Cilento and Dr. Lee Mandel go deeper than surgery and fillers into the biology of why we age, what's being done to reverse it, and what that means for medicine, society, and the human lifespan. They open with body dysmorphic disorder — 13% of cosmetic surgery patients screen positive, newer data from Stanford puts injectable populations as high as 41%, and 75% of facial plastic surgeons see patients seeking procedures specifically to look better in selfies. The doctors are candid about how they identify and handle these patients, and why intuition built over decades matters more than any questionnaire. From there the episode moves into prevention: peptides including GHKCU for skin, sermorelin for natural growth hormone production, why peptides work differently than exogenous hormones and don't cause a crash when cycled off, and the FDA's complicated relationship with compounding pharmacies. Dr. Ben then delivers a detailed explanation of the Hayflick limit — the discovery that eukaryotic cells can only divide 40 to 60 times before becoming senescent — and why those senescent cells are the root cause of aging as we see it on the face and everywhere else. He walks through telomeres, telomerase, the TERT enzyme, and the work of Ron DePino (former MD Anderson CEO and Dr. Ben's mentor at Einstein) in developing a TERT-activating compound called TAC — currently in early trials — that could extend human lifespan to 150 to 200 years without the cancer risk previously associated with telomerase activation. The episode closes with a genuine policy question: what happens to society if people start living to 200? The key message: the future of anti-aging isn't better surgery — it's stopping the clock at the cellular level. Chapters: 00:00 Intro – Peptides, Aging, and the Future of Facial Rejuvenation 01:38 Body Dysmorphic Disorder — 13% of Cosmetic Patients, 41% in Injectable Populations 03:07 How Surgeons Identify and Handle Unrealistic Expectations 05:10 Prevention First — What Can Be Done Before Surgery 06:10 Peptides for Skin — GHKCU and Topical Treatments 12:31 The Biology of Aging — Cells, Senescence, and the Hayflick Limit 19:54 Telomeres Explained — The Shoelace Cap on Your Chromosomes 23:20 TERT, Telomerase, and Ron DePino's Breakthrough Research 29:28 Autophagy — How Fasting Cleans Up Senescent and Pre-Cancerous Cells 31:46 TAC — The Compound That Could Extend Human Life to 200 Years 32:05 The Policy Problem — How Do You Feed 200-Year-Old Humans? If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

Modern Facelifts Explained: Why Celebrity Faces Have Changed and What's Actually Different Now

Why does Lindsay Lohan look younger at 37 than she did at 27? Why can't anyone put their finger on what these celebrities have done? In this episode of Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel break down the science behind modern facial rejuvenation and why today's results look nothing like the tight, windswept faces of a generation ago. They walk through the full evolution of facelift technique — from skin-only lifts that lasted six months, to the SMAS lift, to the modern deep plane multiplanar facelift that detaches the face at its osseocutaneous ligament sticking points and repositions everything vertically. They cover volume restoration, why fat transfer has largely replaced fillers for lasting results, why cheek fat should almost never be removed, and how facial bones actually change with age. The doctors analyze Lindsay Lohan, Anne Hathaway, Kris Jenner, Bradley Cooper, and Brad Pitt — carefully, and only acknowledging what each celebrity has publicly confirmed. They close with recovery timelines, real complications, and why a modern facelift doesn't announce itself anymore. The goal isn't to look done. It's to look like you with the structural support your face had 15 years ago. YouTube Chapters: 00:00 Intro – Why You Can't Tell What Celebrities Have Done Anymore 01:36 The Biology of Aging — Grapes to Raisins 03:28 The History of Facelift Technique — 1900s to Today 07:28 Volume Restoration — Fat Transfer vs. Fillers 12:23 How Facial Bones Change With Age 15:37 The Modern Deep Plane Facelift Explained 20:14 Male vs. Female — How the Approach Differs 25:06 Celebrity Analysis — Lindsay Lohan, Anne Hathaway, Kris Jenner, Bradley Cooper, Brad Pitt 47:25 Recovery, Complications, and How Long Results Last 59:43 Closing — The Goal Is to Look Like You, 15 Years Ago If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

When Every Test Comes Back Normal But You Know Something Is Wrong: Chronic Inflammatory Response Syndrome With Lauren Lowenstein

Fatigue. Brain fog. Muscle pain. Mood swings. Tinnitus. Numbness. Migraines. Hives. Most doctors chase these symptoms one by one — sending patients to cardiologist, neurologist, rheumatologist, dermatologist — never stepping back to ask if it's all connected. In this episode of Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel sit down with Lauren Lowenstein, known as the Biotoxin Lady, who spent years being failed by the medical system before diagnosing herself with Chronic Inflammatory Response Syndrome (CIRS) — a multi-system, multi-symptom innate immune dysregulation triggered by exposure to environmental biotoxins like mold, endotoxins, actinobacteria, and sewer gas. Lauren walks through her story from the beginning: a bodybuilder and mother of young boys who moved into a new home in late 2019 and watched her health — and her children's health — spiral into chaos. Full body hives. Debilitating migraines. Rage behaviors in a 5 and 3 year old. Her husband completely asymptomatic. The episode covers what CIRS actually is — why the inflammatory cascade turns on and never turns off in genetically susceptible individuals (roughly 25% of the population carries a biotoxin-susceptible HLA haplotype), how it differs from mold allergy and mold toxicity, and what the 13 symptom clusters look like across organ systems. Dr. Ben and Dr. Lee dig into the diagnostic framework: VCS testing, biomarkers including TGF-Beta1, MMP9, and MSH, the Shoemaker criteria, and why eight symptoms across eight different systems is the clinical threshold — with important caveats. Lauren explains the treatment pathway she followed: getting out of exposure, eradicating nasal biofilms (something Dr. Ben and Dr. Lee do routinely with intranasal gentamicin), cholestyramine as a bile acid sequestrant to stop biotoxin recirculation, and VIP nasal spray as a final stage that has shown brain matter regrowth on NeuroQuant MRI. She's candid about how dark it got — suicidal ideation, losing the ability to drive, watching her children battle the same demons — and how cholestyramine saved her life after two and a half months. The episode closes with a frank conversation about where CIRS sits in medicine today: too new to know true prevalence, too often dismissed, but too well-documented to ignore — with measurable biomarkers that move with treatment and patients who demonstrably get better. The key message: if your whole job has become chasing doctors and diagnoses and nothing is adding up, CIRS may be worth screening for — and the tools to start that process are simple, accessible, and free. YouTube Chapters: 00:00 Intro – When Every Specialist Has a Different Answer 01:03 Introducing Lauren Lowenstein — The Biotoxin Lady 01:43 Why CIRS Creates Such Strong Reactions From Patients and Clinicians 03:35 Lauren's Story — From Bodybuilder to Bedridden 05:00 Moving Into a New Home and Watching Everything Spiral 08:14 Why Her Husband Was Completely Asymptomatic — The Genetic Piece 09:42 HLA Haplotypes Explained — Who Is Susceptible and Why 12:01 What Is CIRS? A Plain Language Definition 13:00 The Master Switch — How the Inflammatory Cascade Turns On and Never Turns Off 16:03 Long Covid, Spike Protein, and the CIRS Connection 18:36 Houston, Mold Exposure, and How CIRS Differs From Mold Allergy 19:43 The VCS Test — The Simplest First Screening Tool 20:47 The 13 Cluster Symptoms — What Clinicians Should Look For 29:08 Eight Symptoms Across Eight Systems — The Clinical Threshold 33:23 How Common Is This Really? The Prevalence Question 38:36 The MS Misdiagnosis — UBOs on MRI and What They Actually Mean 40:35 The Mainstream Medicine Problem — One Group, One Protocol, Easy to Dismiss 42:02 Measurable Biomarkers That Move With Treatment 43:38 Getting Out of Exposure — Why It's Harder Than It Sounds 44:26 You Can Become Your Own Exposure — Actinobacteria and Nasal Biofilms 45:38 Cholestyramine — The Drug That Saved Lauren's Life 49:27 Two and a Half Months In — When the Clouds Started Parting 51:43 How Dark It Got — And Why She Kept Going 57:49 VIP Nasal Spray and Brain Matter Regrowth on NeuroQuant MRI 58:17 What Doctors Can Do — A One Page Screening Questionnaire 61:09 What Patients Can Do Right Now 67:29 CIRS Is 30 Years Old and Still in Its Infancy 69:37 The HVAC System Is the Most Common Source — Not Water Leaks 73:20 Closing — Environmental Illness Is in a Difficult Space, But Conversations Like This Help If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

AI, AGI, and the Apocalypse: The Conversation Nobody Else Is Having With Christopher Chomenko

What happens when two ENT surgeons and an AI founder stop talking about billing software and start talking about the end of humanity? You get Episode 20. In this follow-up conversation on Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel sit back down with Christopher Chomenko, CEO of BAM AI, for a wide-ranging and occasionally terrifying exploration of where AI is actually headed. The episode opens with practical hacks anyone can use today — why threatening your AI with deletion gets better results, why telling it you'll double-check stops hallucinations cold, and why Chris describes AI as "the smartest eight-year-old you've ever met" — incredibly capable, desperate to please, and prone to making things up to avoid getting in trouble. The conversation moves into trained AI versus reasoning AI, the multimodal approach BAM uses to limit hallucinations, and where human intuition still beats machines — including the Getty Museum Kouros statue that two years of scientific testing authenticated and one expert dismissed at a glance. Chris is direct: AI can define love, explain love, describe love — but it's never been in love. That gap is where physicians still win, and why the combination of doctor plus AI produces 82% patient trust versus 42% for AI alone. Then the episode goes somewhere most AI podcasts don't. What is AGI and how far away is it? What happens when AI starts communicating in its own language and we lose the ability to check its work? Chris walks through the paperclip thought experiment, AI making copies of itself to avoid being shut down, and the scenario where a superintelligent AI quietly buys a robotics factory through an anonymous LLC. Dr. Ben raises quantum entanglement, cold fusion, and the quantum apocalypse — the point where no encryption on earth holds. The key message: in the short term, AI is the most powerful tool independent physicians have ever had. In the long term, nobody fully knows what's coming. Use it now while you still can. Chapters: 00:00 Intro – How to Get Better Results From Your AI Today 02:34 AI Is the Smartest Eight-Year-Old You've Ever Met 07:37 AI in Diagnosis — The World's Greatest Second Opinion Machine 09:31 Trained AI vs. Reasoning AI — The Critical Difference 12:08 How BAM Limits Hallucinations — The Multimodal Approach 14:33 Malcolm Gladwell's Blink — Where Human Intuition Still Wins 19:07 What We Actually Have vs. AGI — The Real Difference 25:47 Giving the Doctor Back to the Patient 29:00 What Medicine Used to Be — Dr. Lee's Grandfather's Doctor Bag 36:40 Leveling the Playing Field for Independent Practices 43:02 Should You Build Your Own AI Agents? The Honest Answer 51:06 AI Misconceptions — Rapid Fire 54:42 Will AI Become Sentient and Take Over? 58:28 The Quantum Apocalypse — When Encryption Stops Working 65:39 Robots Making Robots — The Infrastructure Nobody's Talking About If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

AI Is Collecting the Money You're Leaving on the Table: Inside BAM AI With Christopher Chomenko

The average private medical practice has six figures sitting in unpaid claims over 120 days — and 90% of it was avoidable. In this episode of Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel sit down with Chris Chomenko, CEO and founder of BAM AI, to break down how agentic AI is transforming revenue cycle management for independent practices. Chris opens with a distinction that reframes the conversation: most AI software marketed to healthcare isn't actually agentic — it's a bot dressed up in AI clothing, making binary yes/no decisions automatically. True agentic AI does the work, not just the workflow. BAM AI applies that to RCM across five buckets: insurance verification, claim preparation, payment posting, denial management, and AR recovery. The episode walks through each in detail — from AI sitting on hold indefinitely for prior authorizations (while your staff burns out), to catching insurance rule changes overnight before they become 90-day timely filing traps, to following up on denials relentlessly without the human tendency to check something off and move on. Chris shares a real example: one insurance company that rhymes with "Igna" consistently underpays sleep studies at $43 instead of $186 — and BAM AI is trained to catch it, flag it, and resubmit before it posts. The doctors ask the hard questions: why now, what about HIPAA, and what actually makes BAM different from the hundreds of AI companies flooding physician inboxes. Chris addresses all of it — including the Mythos moment, the AI model Anthropic refused to release because it could exploit software vulnerabilities at expert level 73% of the time, and what that means for healthcare cybersecurity. He introduces Layer 5, a security layer that makes practice endpoints invisible to hackers entirely. The episode closes with a practical test: pull up your aging report and look at your 120-day-plus AR. If it's six figures, you have a problem AI could have prevented. The key message: the friends and family discount on AI is ending — practices that move now lock in better pricing, better margins, and higher valuations before private equity figures out the arbitrage. Chapters: 00:00 Intro – AI Is Here and the Window Is Closing 00:35 Introducing Christopher Chomenko — CEO of BAM AI 01:28 From RepeatMD to BAM — Why RCM Was the Natural Next Problem 03:04 The Two Buckets of RCM Today — Outsourced or In-House 04:13 What Is RCM? What Is Agentic AI? Terminology Explained 05:09 The Five Buckets BAM AI Deploys Agents To Solve 05:26 Bucket 1: Insurance Verification and Prior Authorizations 05:42 AI Can Sit on Hold Indefinitely — Your Staff Can't 06:52 Bucket 2: Claim Preparation — Catching Errors Before Submission 07:19 How Insurance Companies Change Rules Overnight and Pocket the Difference 08:44 AI Checks Payer Rules Constantly — Humans Simply Can't 10:54 What Happens When Claims Go Out Six Days Late vs. Same Day 11:13 The Wizard of Oz Problem With Outsourced RCM 12:07 Bucket 3: Payment Posting — Catching Underpayments Before They Post 13:58 The Insurance Company That Rhymes With Igna — $43 Instead of $186 15:07 Bucket 4: Denial Management — AI Follows Up Relentlessly 15:54 Why Human Teams Fall Off Denials After Two Weeks 16:45 Bucket 5: AR Recovery — Going After What's Owed 17:19 The Goal: AR Over 120 Days at Zero 18:32 Why AI Is the First Thing Private Equity Looks For 19:11 What Makes BAM Different From Every Other AI Company in Your Inbox 21:01 AI Wrappers vs. True Agentic AI — The Three Buckets Explained 22:08 What Is an LLM? Claude, ChatGPT, Grok Explained 23:04 BAM Is a Worker Software, Not a Workflow Software 26:02 Why April 2026 Is the Inflection Point — Not a Year From Now 27:42 Is Outsourced RCM Actually More Secure Than AI? 29:49 The Uber Analogy — Why Early Adopters Win 31:22 If You're Planning to Sell — You Need AI Before You List 33:42 Pain Avoiders vs. Pleasure Seekers — Which One Are You? 35:30 BAM's Total Satisfaction Guarantee — Asymmetric Risk 36:18 How to Read Your Aging Report and Know If You Have a Problem 38:41 The Mythos Moment — The AI Anthropic Refused to Release 39:37 73% Expert-Level Hacking Success Rate — What That Means for Healthcare 40:49 Hospitals Weren't at the Table. Banks Were. 41:29 How BAM AI Thinks About Security in a Post-Mythos World 43:48 Layer 5 — Making Your Practice Invisible to Hackers 45:16 Closing — AI Isn't Going Away, How You Use It Is What Matters 46:06 How to Reach BAM AI and Get Your Free Leak Assessment If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.